Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Oct 2026 for Xos, Inc..
Filing timeline
BuySaleEdward J. Rapp
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
Closed purchases
Market purchases
7
Positive at T+90
57%
Median T+90
+0.3%
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -57.2%Entry US$18.63 · Close at T+365 US$7.98
- -78.7%Entry US$120.30 · Close at T+365 US$25.68
- -81.3%Entry US$232.80 · Close at T+365 US$43.50
- +17.8%Entry US$90.61 · Close at T+365 US$106.70
- +31.4%Entry US$73.40 · Close at T+365 US$96.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Edward J. Rapp: trading record in brief
Edward J. Rapp serves as a Director at Xos, Inc. (29 filings) and AbbVie Inc. (17), for a total of 46 filings published between May 10, 2016 and October 13, 2026. The record has no sale: 7 purchases, EUR 1.6 million in total, with a median of EUR 226,692. The largest, EUR 443,746, is from June 26, 2019 and concerns AbbVie Inc.; next come November 18, 2021 (EUR 377,010, at Xos, Inc.) and July 31, 2017 (EUR 238,327, at AbbVie Inc.). The 3 purchases at Xos, Inc. and the 4 at AbbVie Inc. make up the whole set.
The rest is equity pay, with 37 grants. The yearly count goes from 1 in 2016 to 7 in 2025. Six filings fall in the last 12 months, with no purchase. The median publication delay is 4 days.
At Xos, Inc., 2 of Rapp's trades fall within 30 days of a trade by George N. Mattson, all in the same direction.
Companies and markets linked to Edward J. Rapp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
1,814 shares0Common StockSEC:0001193125-26-420688:0
60,584 shares0Common StockSEC:0001193125-26-303481:1
2,670 shares0Common StockSEC:0001193125-26-303481:0
1,118 shares0Common Stock, $0.01 par valueSEC:0001171780-26-000010:0
5,182 shares0Common StockSEC:0001171780-26-000008:0
2,401 shares0Common StockSEC:0001171780-26-000004:0
1,883 shares0Common StockSEC:0001171780-25-000006:0
1,601 shares0Common StockSEC:0001819493-25-000101:1
62,377 shares0Common StockSEC:0001819493-25-000101:0
1,203 shares0Common Stock, $0.01 par valueSEC:0001415889-25-012792:0
1,407 shares0Common StockSEC:0001819493-25-000056:0
1,475 shares0Common StockSEC:0001819493-25-000029:0
1,065 shares0Common StockSEC:0001819493-25-000010:0
1,065 shares0Common StockSEC:0001819493-24-000206:0
717 shares0Common StockSEC:0001819493-24-000115:1
28,694 shares0Common StockSEC:0001819493-24-000115:0
1,322 shares0Common Stock, $0.01 par valueSEC:0001415889-24-012528:0
445 shares0Common StockSEC:0001819493-24-000052:0
650 shares0Common StockSEC:0001819493-24-000012:0
15,151 shares0Common StockSEC:0001819493-23-000239:0
15,151 shares0Common StockSEC:0001819493-23-000190:0
444,444 shares0Common StockSEC:0001819493-23-000142:0
1,450 shares0Common Stock, $0.01 par valueSEC:0001415889-23-007674:0
7,936 shares0Common StockSEC:0001819493-23-000068:0
7,936 shares0Common StockSEC:0001819493-23-000015:0
25 of 46 declarations
